FindTrial
Sign In

D004311

4 trials

Sponsors

Shimokawahara Hiroto, Sasaki Ryohei, Kinoshita Shigeru, Fukata Satoshi

Conditions

Cervical cancer,Endometrial cancer,Vaginal cancer Gynecologic tumor,Cervical cancer,Endometrial cancer,Vaginal cancerEyestrain Eye painOveractive bladder OABchronic thromboembolic pulmonary hypertension CTEPH

Phase 2

THERAPY-HYBRID-BPA trial
Active, not recruitingJPRN-jRCTs041200052
Shimokawahara Hirotochronic thromboembolic pulmonary hypertension CTEPH
Start: 2021-06-30Target: 72Updated: 2026-06-29
Evaluation of the Effect of Reduced Coenzyme Q10 (CoQ10) for Reducing Acute Adverse Events During Radiotherapy
Active, not recruitingJPRN-jRCTs051210039
Sasaki RyoheiCervical cancer,Endometrial cancer,Vaginal cancer Gynecologic tumor,Cervical cancer,Endometrial cancer,Vaginal cancer
Start: 2021-08-03Target: 60Updated: 2026-06-29
Improvement effect and safety of overactive bladder symptoms
Active, not recruitingJPRN-jRCTs061220050
Fukata SatoshiOveractive bladder OAB
Start: 2022-08-29Target: 100Updated: 2026-06-29
low concentration cyclopentolate hydrochloride ophthalmic solution for eyestrain
RecruitingJPRN-jRCTs051250238
Kinoshita ShigeruEyestrain Eye pain
Start: 2026-02-27Target: 80Updated: 2026-06-29

Related Papers

Oral 5‑aminolevulinic acid for overactive bladder: a double‑blind, randomized, placebo‑controlled pilot trial
European journal of medical research2026-02-20
Effect of riociguat on exercise following balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension in Japan (THERAPY-HYBRID-BPA): a multicentre, double-blind, randomised, controlled, phase 4 trial.
2025-07-232 citations